Travere Therapeutics' Amortizatization of Intangibles rose 122.39% to $2.3 million in Q4 2023 from the same period last year, while for Dec 2023 it was $5.7 million, marking a year-over-year increase of 717.43%. This contributed to the annual value of $4.5 million for FY2024, which is 39.18% down from last year.
As of Q4 2023, Travere Therapeutics' Amortizatization of Intangibles stood at $2.3 million, which was up 22.84% from $1.9 million recorded in Q3 2023.
Travere Therapeutics' Amortizatization of Intangibles' 5-year high stood at $2.3 million during Q4 2023, with a 5-year trough of -$697,000 in Q4 2021.
Over the past 3 years, Travere Therapeutics' median Amortizatization of Intangibles value was -$199,500 (recorded in 2021), while the average stood at $281,900.
As far as peak fluctuations go, Travere Therapeutics' Amortizatization of Intangibles skyrocketed by 295.10% in 2019, and later plummeted by 2,022.22% in 2020.
Travere Therapeutics' Amortizatization of Intangibles (Quarterly) stood at $9,000 in 2019, then tumbled by 2,022.22% to -$173,000 in 2020, then crashed by 302.89% to -$697,000 in 2021, then spiked by 246.77% to $1.0 million in 2022, then surged by 122.39% to $2.3 million in 2023.
Its Amortizatization of Intangibles stands at $2.3 million for Q4 2023, versus $1.9 million for Q3 2023 and $1.0 million for Q4 2022.

Peer Comparison

Historic Data

Download Data 🔒

Date	Value